SOHPIA ANTIPOLIS CEDEX — The European Society of Cardiology (ESC) has announced the forthcoming EHRA 2021, an online scientific congress scheduled from April 23 to 25. This premier event will spotlight the latest research breakthroughs and upcoming treatments in heart rhythm disorders, presenting a diverse array of topics poised to shape the future of cardiovascular care, according to a press release published on EuropaWire.

EHRA 2021 promises to unveil novel insights through scientific abstracts, exploring intriguing correlations such as the impact of season of birth on health, the significance of weight loss post-atrial fibrillation treatment, and the interplay between cardiac devices and mental health. Attendees can expect to delve into groundbreaking studies on arrhythmias and cannabis use, pregnancy-related complications, the nexus between cancer and cardiac health, and much more.

A blend of live and on-demand sessions will illuminate the most pressing issues in arrhythmia management, pacing, and electrophysiology. These sessions will feature dynamic panel discussions, interactive Q&A sessions with the audience, and live ablation procedures streamed from leading centers across Europe.

One of the congress’s highlights will be a dedicated session on leveraging digital technologies to enhance the prediction, detection, and treatment of sudden cardiac arrest. This session will explore the potential of artificial intelligence, mobile apps, and drones in delivering timely interventions to save lives. Professor Isabelle Van Gelder, the scientific chair, emphasized the critical role of swift intervention in cases of sudden cardiac arrest, underscoring the potential of drones in expediting defibrillator deployment to bystanders.

In addition to cutting-edge research, EHRA 2021 will address contentious topics such as the management of sudden cardiac death in athletes and the debate surrounding weight loss prerequisites for cardiac ablation procedures. Experts will provide insights into the screening protocols for athletes at risk of lethal arrhythmias and the judicious use of defibrillators in sports. Furthermore, the congress will explore the impact of remote monitoring on patient empowerment, shedding light on innovative strategies to alleviate anxiety among patients receiving implantable cardioverter-defibrillators (ICDs).

The congress will also spotlight significant advancements in managing arrhythmias in pediatric and adult patients with congenital heart diseases, showcasing the latest developments in imaging techniques and ablation procedures. Professor Van Gelder emphasized the remarkable progress made in treating pediatric patients, resulting in lower complication rates and improved outcomes.

EHRA 2021 serves as a premier platform for scientists, healthcare professionals, and opinion leaders worldwide to converge and exchange insights on arrhythmia management. Press registration is now open, offering access to the latest updates and press releases from Europe’s leading arrhythmia conference.